New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›Amundi›HLTW

HLTW

Amundi MSCI World Health Care UCITS ETF

Acc

EUR

Passive ETF Equity

The HLTW Exchange Traded Fund (ETF) is provided by Amundi. It is built to track an index: MSCI World Health Care Index. This ETF provides synthetic exposure, by owning its shares you earn the return of the index indirectly through the use of derivatives or a swap (i.e. a contract with a financial institution which delivers the return of the index). The dividend policy is capitalization.

€506.47

-€2 (-0.39%) 2 days ago

7:00 AM 07/31/26 Closed

1D price range

€504.04€511.73

52W price range

€410.67€525.51

YTD Perf.

+6.23%

YTD Flows

Annualized volatility

Fund AuM

€913M

Share class AuM

€826M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

LU0533033238

TER

0.3%

Inception date

8/19/2010

Issuer

Amundi

Benchmark

MSCI World Health Care Index

Replication method

Dividend policy

Capitalization

Compare similar ETFs

No content available for this fund

API

PerformanceDec 31, 2025 - Jul 30, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

97.49%

Consumer Non-Cyclicals

1.63%

Other

0.82%

Latest HLTW news

No content available for this fund

FAQ about HLTW

HLTW is a Passive ETF. This ETF provides exposure to Large and Mid-Cap Developed markets Health Care Equities.

HLTW tracks the MSCI Daily Total Return World Net Health Care Index - EUR, through a unfunded swap replication method.

HLTW carries a total expense ratio (TER) of 0.3%, indicating the annual cost for holding the fund.

HLTW was introduced to the market on August 19, 2010. It trades on Finland, among other exchanges

Amundi MSCI World Health Care UCITS ETF, HLTW, is provided by Amundi. Learn more about Amundi here.

Yes, HLTW is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .

HLTW oversees €826M in assets as of July 30, 2026.

HLTW follows a capitalizing, meaning it reinvests income within the fund.

As of June 30, 2026, HLTW has significant geographic allocations in USA, Switzerland and United Kingdom.

As of June 30, 2026, HLTW focuses largely on Healthcare and Consumer Non-Cyclicals.

As of June 30, 2026, HLTW holds 113 positions in its portfolio, with 58.27% of assets concentrated in its top 15 holdings.

As of June 30, 2026, HLTW top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

The base currency of HLTW is EUR.

Top 10 holdings

Data as of 06/30/26

Eli Lilly & Co.

11.91%

Johnson & Johnson

7.53%

AbbVie, Inc.

5.50%

UnitedHealth Group, Inc.

4.77%

Merck & Co., Inc.

3.91%

Roche Holding AG

3.58%

Novartis AG

3.51%

AstraZeneca PLC

3.51%

Amgen, Inc.

2.37%

Thermo Fisher Scientific, Inc.

2.34%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

Amundi MSCI World Health Care UCITS ETF

FAQ about HLTW

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US